Astrazeneca PLC (AZN)

AstraZeneca said its net income increased 23 percent to $2.12 billion from $1.73 billion a year earlier. Earnings excluding restructuring and other one-time costs gained to $1.68 a share from $1.32, beating analysts' forecasts. Third-quarter sales gained 5.4 percent to $8.2 billion.
Earnings rose on Swine Flu vaccine.

Oct 29 · 11:33:00 AM · Source: Company News Release
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter